Interestingly, bFGF and PDGF expression was increased in the endothelial cells, pericytes and tumor cells upon bevacizumab treatment, indicating that the inhibition of VEGF alone is not sufficient to maintain the inhibition of neovascularization due to resistance by bFGF and pericyte coverage by PDGF. Here, FGF2 is linked to neoplasm.